Mobile

Randomized Phase 3 Trial of Decitabine Versus Patient's Choice with Physician's Advice of Either Supportive Care or Low-dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute M...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-004503-11

Randomized Phase 3 Trial of Decitabine Versus Patient's Choice with Physician's Advice of Either Supportive Care or Low-dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the overall survival in patients 65 years and older who have newly diagnosed de novo or secondary Acute Myloid Leukemia and either poor or intermediate risk cytogenetics who are randomly assigned to receive either decitabine or patients choice with physicians advice of either supportive care or low dose cytarabine.

Critère d'inclusion

  • Acute Myloid Leukemia

Liens